Skip to content

Kunitz-type protease inhibitor 1 (SPINT1)

Homo sapiens — UniProt O43278

Gene: SPINT1Homo sapiensSwissProt reviewed

Data last refreshed: (UniProt release unknown)

Key facts

Kunitz-type protease inhibitor 1 (SPINT1) is a protein from Homo sapiens identified by UniProt accession O43278, 529 residues long. MolForge cross-references it against 0 known binders and 114 disease associations.

  • UniProt accession: O43278; gene symbol SPINT1.
  • Organism: Homo sapiens.
  • Length: 529 amino acids.
  • Top disease associations (Open Targets): neurodegenerative disease, blood protein measurement and glioblastoma multiforme.
  • 3D structure: AlphaFold model available.

Target properties

Protein nameKunitz-type protease inhibitor 1
UniProt accessionO43278
GeneSPINT1
OrganismHomo sapiens
Length529 residues
Molecular weight—
EC numbers—
Target class—
Subcellular location—
Keywords—

Druggability

Target tractability assessment (Open Targets + pocket analysis). No approved drug

Druggability tierMEDIUM
Druggability score—
Pocket score—
Max clinical phase—

Disease associations (114)

Diseases linked to this target (Open Targets).

  • neurodegenerative disease · score 0.39
  • blood protein measurement · score 0.21
  • glioblastoma multiforme · score 0.18
  • breast adenocarcinoma · score 0.18
  • head and neck squamous cell carcinoma · score 0.17
  • cutaneous melanoma · score 0.14
  • hepatocellular carcinoma · score 0.09
  • esophageal squamous cell carcinoma · score 0.08
  • neoplasm · score 0.06
  • metabolite measurement · score 0.05

3D Structure (1)

Experimental (PDB) and predicted (AlphaFold) structures for this protein.

StructureSourceMethodMean pLDDTResolution (Å)
AF-O43278-F1alphafoldPREDICTED76.19—

Experimental structures are not indexed in MolForge yet — search RCSB PDB for O43278.

Amino-acid sequence (529 residues)

MAPARTMARA RLAPAGIPAV ALWLLCTLGL QGTQAGPPPA PPGLPAGADC LNSFTAGVPG FVLDTNASVS NGATFLESPT VRRGWDCVRA CCTTQNCNLA LVELQPDRGE DAIAACFLIN CLYEQNFVCK FAPREGFINY LTREVYRSYR QLRTQGFGGS GIPKAWAGID LKVQPQEPLV LKDVENTDWR LLRGDTDVRV ERKDPNQVEL WGLKEGTYLF QLTVTSSDHP EDTANVTVTV LSTKQTEDYC LASNKVGRCR GSFPRWYYDP TEQICKSFVY GGCLGNKNNY LREEECILAC RGVQGGPLRG SSGAQATFPQ GPSMERRHPV CSGTCQPTQF RCSNGCCIDS FLECDDTPNC PDASDEAACE KYTSGFDELQ RIHFPSDKGH CVDLPDTGLC KESIPRWYYN PFSEHCARFT YGGCYGNKNN FEEEQQCLES CRGISKKDVF GLRREIPIPS TGSVEMAVAV FLVICIVVVV AILGYCFFKN QRKDFHGHHH HPPPTPASST VSTTEDTEHL VYNHTTRPL

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

Which diseases are associated with SPINT1?

The strongest Open Targets associations for SPINT1 are neurodegenerative disease, blood protein measurement, glioblastoma multiforme, breast adenocarcinoma and head and neck squamous cell carcinoma.

How long is the SPINT1 protein?

The Homo sapiens SPINT1 protein (UniProt O43278) is 529 amino acids long.

Browse: Targets: S · all protein targets A–Z · drugs A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Explore Kunitz-type protease inhibitor 1 with MolForge

Find binders, run structure-based screening, and map this target across diseases and approved drugs with our AI-powered platform.

Browse all targets

Quick facts

UniProtO43278
GeneSPINT1
OrganismHomo sapiens
Length529
Binders0
Diseases114
View on UniProt